These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 35899316)

  • 21. Mucolytic bacteria license pathobionts to acquire host-derived nutrients during dietary nutrient restriction.
    Sugihara K; Kitamoto S; Saraithong P; Nagao-Kitamoto H; Hoostal M; McCarthy C; Rosevelt A; Muraleedharan CK; Gillilland MG; Imai J; Omi M; Bishu S; Kao JY; Alteri CJ; Barnich N; Schmidt TM; Nusrat A; Inohara N; Golob JL; Kamada N
    Cell Rep; 2022 Jul; 40(3):111093. PubMed ID: 35858565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathobiont release from dysbiotic gut microbiota biofilms in intestinal inflammatory diseases: a role for iron?
    Buret AG; Motta JP; Allain T; Ferraz J; Wallace JL
    J Biomed Sci; 2019 Jan; 26(1):1. PubMed ID: 30602371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
    Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
    Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal colonization with phylogenetic group B2 Escherichia coli related to inflammatory bowel disease: a systematic review and meta-analysis.
    Petersen AM; Halkjær SI; Gluud LL
    Scand J Gastroenterol; 2015; 50(10):1199-207. PubMed ID: 25910859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prevalence of mucosa-associated diffusely adherent Escherichia coli in children with inflammatory bowel disease.
    Walczuk U; Sobieszczańska B; Turniak M; Rzeszutko M; Duda-Madej A; Iwańczak B
    Adv Clin Exp Med; 2019 Jul; 28(7):899-905. PubMed ID: 31066244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineered and wild-type L. lactis promote anti-inflammatory cytokine signalling in inflammatory bowel disease patient's mucosa.
    Simčič S; Berlec A; Stopinšek S; Štrukelj B; Orel R
    World J Microbiol Biotechnol; 2019 Feb; 35(3):45. PubMed ID: 30810891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the human gut microbiome during travelers' diarrhea.
    Youmans BP; Ajami NJ; Jiang ZD; Campbell F; Wadsworth WD; Petrosino JF; DuPont HL; Highlander SK
    Gut Microbes; 2015; 6(2):110-9. PubMed ID: 25695334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacterial imbalance and gut pathologies: Association and contribution of E. coli in inflammatory bowel disease.
    Khan S; Imran A; Malik A; Chaudhary AA; Rub A; Jan AT; Syed JB; Rolfo C
    Crit Rev Clin Lab Sci; 2019 Jan; 56(1):1-17. PubMed ID: 30373492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The autoimmune susceptibility gene,
    Shawki A; Ramirez R; Spalinger MR; Ruegger PM; Sayoc-Becerra A; Santos AN; Chatterjee P; Canale V; Mitchell JD; Macbeth JC; Gries CM; Tremblay ML; Hsiao A; Borneman J; McCole DF
    Gut Microbes; 2020 Nov; 11(6):1547-1566. PubMed ID: 32586195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intestinal dysbiosis: novel mechanisms by which gut microbes trigger and prevent disease.
    Underwood MA
    Prev Med; 2014 Aug; 65():133-7. PubMed ID: 24857830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reshaping of bacterial molecular hydrogen metabolism contributes to the outgrowth of commensal
    Hughes ER; Winter MG; Alves da Silva L; Muramatsu MK; Jimenez AG; Gillis CC; Spiga L; Chanin RB; Santos RL; Zhu W; Winter SE
    Elife; 2021 Jun; 10():. PubMed ID: 34085924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct inflammatory and cytopathic characteristics of Escherichia coli isolates from inflammatory bowel disease patients.
    Jensen SR; Mirsepasi-Lauridsen HC; Thysen AH; Brynskov J; Krogfelt KA; Petersen AM; Pedersen AE; Brix S
    Int J Med Microbiol; 2015 Dec; 305(8):925-36. PubMed ID: 26522075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early enterocyte responses to enteropathogenic E. coli.
    Hecht GA
    J Pediatr Gastroenterol Nutr; 2005 Apr; 40 Suppl 1():S32. PubMed ID: 15805842
    [No Abstract]   [Full Text] [Related]  

  • 34. Ulcerative Colitis-associated
    Yang H; Mirsepasi-Lauridsen HC; Struve C; Allaire JM; Sivignon A; Vogl W; Bosman ES; Ma C; Fotovati A; Reid GS; Li X; Petersen AM; Gouin SG; Barnich N; Jacobson K; Yu HB; Krogfelt KA; Vallance BA
    Gut Microbes; 2020 Nov; 12(1):1847976. PubMed ID: 33258388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-Aminosalicylic Acid Ameliorates Colitis and Checks Dysbiotic Escherichia coli Expansion by Activating PPAR-γ Signaling in the Intestinal Epithelium.
    Cevallos SA; Lee JY; Velazquez EM; Foegeding NJ; Shelton CD; Tiffany CR; Parry BH; Stull-Lane AR; Olsan EE; Savage HP; Nguyen H; Ghanaat SS; Byndloss AJ; Agu IO; Tsolis RM; Byndloss MX; Bäumler AJ
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phylogenetic analysis of inflammatory bowel disease associated Escherichia coli and the fimH virulence determinant.
    Sepehri S; Kotlowski R; Bernstein CN; Krause DO
    Inflamm Bowel Dis; 2009 Nov; 15(11):1737-45. PubMed ID: 19462430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-based Definition of an Inflammatory Bowel Disease-associated Adherent-Invasive Escherichia coli Pathovar.
    Desilets M; Deng X; Rao C; Ensminger AW; Krause DO; Sherman PM; Gray-Owen SD
    Inflamm Bowel Dis; 2016 Jan; 22(1):1-12. PubMed ID: 26444104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colorectal cancer-inflammatory bowel disease nexus and felony of Escherichia coli.
    Khan AA; Khan Z; Malik A; Kalam MA; Cash P; Ashraf MT; Alshamsan A
    Life Sci; 2017 Jul; 180():60-67. PubMed ID: 28506682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory bowel disease-associated
    Chang R; Chen J; Zhong Z; Li Y; Wu K; Zheng H; Yang Y
    Front Cell Infect Microbiol; 2022; 12():983169. PubMed ID: 36093189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases.
    Bianchi L; Gaiani F; Vincenzi F; Kayali S; Di Mario F; Leandro G; De' Angelis GL; Ruberto C
    Acta Biomed; 2018 Dec; 89(9-S):153-157. PubMed ID: 30561409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.